Thursday, May 5, 2005

Meeting the Challenge, Making the Alliance Work!

7:30    Morning Coffee

8:00    Chairperson's Opening Remarks

8:00    Reports From Wednesday Roundtables

8:05     Removing Barriers: The Challenge of Managing Conflict
• Understand why conflict exists
• Methods for minimizing conflict 
• Focus on Win:Win conflict resolution 
Gregg Stetsko, Ph.D., Vice President, Operations, Amylin Pharmaceuticals, Inc.

8:50    Creating and Maintaining an Aligned Product Strategy: A Case Study
	Learn from a real-life case study: • Why the alliance faltered, and how they regained alignment • Methods for establishing an effective team, with shared vision • Integrating change -- while keeping the vision in sight -- as the alliance evolves Mary Linton Peters, Principal, Strategic Decisions Group

10:30    Eli Lilly: Applying Lessons Learned for Managing Alliances
• Strategies for aligning alliance commitments
• Tools and training for developing an alliance capability
• Tracking deliverables: people, capabilities, knowledge management
• Three-year lessons learned and experiences
Michael O. Ransom, Office of Alliance Management, Eli Lilly and Company 

12:00    Networking Luncheon

1:00    Fixing a Broken Alliance -- Why it Broke, How it Got There, and the Re-Launch Effort to Get it Back on Track: An Interactive Case Study

• Hear about a potentially multi-billion dollar alliance falling apart • See, in real terms, how the oft-cited "relationship problems" can truly impede alliance success • Learn about how and why both parties - well intentioned, good business people trying to get the job done - contributed to the difficulties • See what could have been done to stay out of trouble in the first place, and what was done to get it back on track • Learn about how an organizational capability to successfully manage alliance relationships would have supported such an overall effort • Share your own experiences Stuart Kliman, Director, Vantage Partners

1:45    Crossing the Valley of Death: Sparking Collaborative Innovation
• Early stage research creates uncertainties and costs, often characterized as the "valley of death"
• Approaches to crossing this valley are outlined
• Specific examples are discussed
Richard B. Chapas, Ph.D., Director, Industry Collaboration, Battelle

2:30    Joint Partner Presentation
Mark Della Porta, Senior Director and Site Head, Strategic Alliances, Pfizer Global R&D
in partnership with David K. Lyon, Ph.D., Bend Research, Inc.
As partners in a long term alliance, there have been many ups and downs to manage over a substantial period of time; we'll highlight those issues and how they were resolved to elucidate some points that are valuable as companies manage more long-term alliances, "lessons learned" that are, in fact, applicable to alliances in general, duration notwithstanding.

3:30    Networking Refreshment Break

3:45    Case Study of a Biotech-Biotech Alliance: Genzyme's Collaboration with Cambridge Antibody Technology
	• Challenges Inherent in Biotech-Biotech Alliances  • Addressing Cultural Differences • Evolution of Alliance Management in Genzyme's Partnering Initiative  • Lessons Learned for Long-Term Alliance Success Michele Keough, Director of Program Management, Genzyme Corporation

4:30    Creating and Managing Maturing Brand Alliances -- Pharma View
• Identifying Value Creation Opportunities
• Sharing risk
• Challenging deal issues
• Managing for success
William F. Mongan, Senior Director, Licensing Partnerships and Commercial Development, AstraZeneca

5:15    Wrap-Up and Closing Comments

            Close of Congress

Call for Sponsors
Showcase your company’s expertise, brand your solutions and develop revenue opportunities with qualified decision-makers by becoming a Sponsor! If you want to discuss sponsoring at this conference, please contact Arnold Wolfson at 781-972-5431, awolfson@healthtech.com